Usefulness of PRP Therapy in Androgenic Alopecia

Zahed Parvez,Afia Tahsin Shobnom,Samina Akter

doi:10.24018/ejmed.2021.3.3.897

Zahed Parvez, Afia Tahsin Shobnom + Show 1 more

Open Access

https://doi.org/10.24018/ejmed.2021.3.3.897

Copy DOI

Abstract

Alopecia means loss of hair. Primarily there are two types of alopecia. Non-cicatricial alopecia and Cicatricial alopecia. Androgenic alopecia is non cicatricial localized alopecia and displays relatively high rates of occurrence in both men and women. Injections of platelet-rich plasma (PRP) have shown to be a successful regenerative treatment for androgenic alopecia. It is a well-tolerated procedure and easy to perform. The objective clinical results are good. It is safe and non-allergenic. In our institution, more than 300 patients were given PRP and their terminal hair mass, hair texture, anagen/telogen hair ratio, keratinocyte proliferation, blood vessel density, and other factors were assessed. More than 85 percent of patients who underwent PRP treatment, had a very positive outcome.

Highlights

Fifty percent of men will experience some degree of androgenic alopecia (AGA), known as male-pattern baldness or MPHL, by age 50, and nearly 50 percent of women will experience AGA over the course of her lifetime [1]
Between 2019 and 2020, all patients with androgenic alopecia who had failed to advance on topical Minoxidil and finasteride were considered for Platelet-rich plasma (PRP) treatment
Patients found a substantial decrease in hair loss between the fifth and sixth dose

Summary

INTRODUCTION

Fifty percent of men will experience some degree of AGA, known as male-pattern baldness or MPHL, by age 50, and nearly 50 percent of women will experience AGA (female-pattern hair loss, FPHL) over the course of her lifetime [1]. Given the prevalence of hair loss in these populations, targeted therapies that reduce the appearance of thinning by delaying, arresting, or reversing the underlying pathology are highly desirable. Topical Minoxidil and oral finasteride are the only FDA-approved treatments for androgenic alopecia (AGA) [1]. Platelet-rich plasma (PRP) is gaining popularity as a treatment option for androgenic alopecia because of its rapid response

METHODS

RESULTS

DISCUSSION

CONCLUSION